Arvinas (NasdaqGS:ARVN) Q4 2025 Earnings call February 24, 2026 08:00 AM ET Company ParticipantsAndrew Saik - CFOAngela Cacace - CSOJeff Boyle - Head of Investor RelationsJonathan Miller - Managing Director of Biotech and Pharma Equity ResearchManoj Radder - VPNoah Berkowitz - CMORandy Teel - President and CEOSrikripa Devarakonda - VP of Biotechnology Equity ResearchConference Call ParticipantsDaniel Bronder - Research AnalystDerek Archila - Managing Director and Co-Head of Therapeutics Research & Senior Bi ...

Arvinas (NasdaqGS:ARVN) Q4 2025 Earnings call February 24, 2026 08:00 AM ET Speaker14Thank you. I will now turn the call over to Jeff Boyle, Head of Investor Relations. Jeff, you may begin.Speaker9Good morning, everyone, and thank you for joining us. Earlier today, we issued a press release with our fourth quarter and full year 2025 financial results, which is available in the investor and media section of our website at arvinas.com. Joining us on the call today, we have Randy Teel, our President and CEO, N ...